This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lass-Flörl, C.
Right arrow Articles by Fille, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lass-Flörl, C.
Right arrow Articles by Fille, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2008, p. 3637-3641, Vol. 52, No. 10
0066-4804/08/$08.00+0     doi:10.1128/AAC.00662-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Activities of Antifungal Agents against Yeasts and Filamentous Fungi: Assessment according to the Methodology of the European Committee on Antimicrobial Susceptibility Testing {triangledown}

Cornelia Lass-Flörl,* Astrid Mayr, Susanne Perkhofer, Guido Hinterberger, Johann Hausdorfer, Cornelia Speth, and Manfred Fille

Department of Hygiene, Microbiology and Social Medicine, Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria

Received 20 May 2008/ Returned for modification 25 June 2008/ Accepted 28 July 2008

We compared the activities of antifungal agents against a wide range of yeasts and filamentous fungi. The methodology of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) for yeasts and spore-forming molds was applied; and a total of 349 clinical isolates of Candida spp., other yeast species, Aspergillus spp., and nondermatophyte non-Aspergillus spp. were investigated. The average geometric mean (GM) of the MICs of the various drugs for Candida spp. were as follows: amphotericin B (AMB), 0.55 µg/ml; liposomal amphotericin B (l-AMB); 0.35 µg/ml; itraconazole (ITC), 0.56 µg/ml; voriconazole (VRC), 0.45 µg/ml; posaconazole (POS), 0.44 µg/ml; and caspofungin (CPF), 0.45 µg/ml. The data indicated that the majority of Candida spp. were susceptible to the traditional and new antifungal drugs. For Aspergillus spp., the average GM MICs of AMB, l-AMB, ITC, VRC, POS, and CPF were 1.49 µg/ml, 1.44 µg/ml, 0.65 µg/ml, 0.34 µg/ml, 0.25 µg/ml, and 0.32 µg/ml, respectively. For the various zygomycetes, the average GM MICs of AMB, l-AMB, ITC, and POS were 1.36 µg/ml, 1.42 µg/ml, 4.37 µg/ml, and 1.65 µg/ml, respectively. Other yeastlike fungi and molds displayed various patterns of susceptibility. In general, the minimal fungicidal concentrations were 1 to 3 dilutions higher than the corresponding MICs. POS, AMB, and l-AMB showed activities against a broader range of fungi than ITC, VRC, and CPF did. Emerging pathogens such as Saccharomyces cerevisiae and Fusarium solani were not killed by any drug. In summary, the EUCAST data showed that the in vitro susceptibilities of yeasts and filamentous fungi are variable, that susceptibility occurs among and within various genera and species, and that susceptibility depends on the antifungal drug tested. AMB, l-AMB, and POS were active against the majority of pathogens, including species that cause rare and difficult-to-treat infections.

* Corresponding author. Mailing address: Department of Hygiene, Microbiology and Social Medicine, Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Fritz Pregl Str. 3, Innsbruck 6020, Austria. Phone: 43 512 9003 70725. Fax: 43 512 9003 73700. E-mail: Cornelia.lass-floerl{at}i-med.ac.at

{triangledown} Published ahead of print on 11 August 2008.

Antimicrobial Agents and Chemotherapy, October 2008, p. 3637-3641, Vol. 52, No. 10
0066-4804/08/$08.00+0     doi:10.1128/AAC.00662-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Montone, K. T. (2009). Differentiation of Fusarium From Aspergillus Species by Colorimetric In Situ Hybridization in Formalin-Fixed, Paraffin-Embedded Tissue Sections Using Dual Fluorogenic-Labeled LNA Probes. Am J Clin Pathol 132: 866-870 [Abstract] [Full Text]  
  • Crandon, J. L., Banevicius, M. A., Fang, A. F., Crownover, P. H., Knauft, R. F., Pope, J. S., Russomanno, J. H., Shore, E., Nicolau, D. P., Kuti, J. L. (2009). Bronchopulmonary Disposition of Intravenous Voriconazole and Anidulafungin Given in Combination to Healthy Adults. Antimicrob. Agents Chemother. 53: 5102-5107 [Abstract] [Full Text]  
  • Dimopoulos, G., Velegraki, A., Falagas, M. E. (2009). A 10-Year Survey of Antifungal Susceptibility of Candidemia Isolates from Intensive Care Unit Patients in Greece. Antimicrob. Agents Chemother. 53: 1242-1244 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»